We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Cancer Cells Adjust Their "Velcro" To Enhance Their Spread

Read time: 1 minute

Cancer cells remain clumped together via a sort of 'Velcro' which allows them to adhere to each other wherever they appear. In order for cancer cells to leave a tumour and spread throughout the body during metastatic processes, cancer cells must reduce their adhesion and increase their ability to migrate. They can do this by changing the amount and type of proteins on their surface.

University of Louvain (UCLouvain) research conducted by Henri-François Renard and François Tyckaert and directed by Professor Pierre Morsomme targeted these surface proteins, particularly one called CD166, a kind of microscopic 'Velcro' which allows the cells to stick together.

UCLouvain researchers observed that certain cancer cells are, in fact, capable of decreasing the abundance of this 'Velcro' (CD166) on their surface. More specifically, these cells have found a way to reduce the adhesion of their surface by redirecting it into small internal vesicles: this is a mechanism called endocytosis, which UCLouvain's researchers highlighted in their study published in the prestigious scientific journal Nature Communications.

If there is less adhesion, owing to less 'Velcro' (CD166) on the surface of cancer cells, they stick together less and therefore migrate more easily.

Next steps?

This fundamental mechanism still has many secrets to reveal. But UCLouvain researchers hypothesise that it could contribute to the formation of metastases which allow cancer to spread. And who knows, in the future this will perhaps make it possible to develop new solutions that block metastases and thus slow down the development of certain cancers.

Reference: Renard, H., Tyckaert, F., Lo Giudice, C. et al. (2020) Endophilin-A3 and Galectin-8 control the clathrin-independent endocytosis of CD166. Nat Commun. DOI: https://doi.org/10.1038/s41467-020-15303-y

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.